Cargando…
Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody
Invariant natural killer T cells (iNKTs) directly kill tumor cells and trans-activate the anti-tumor functions of dendritic cells (DC), natural killer (NK) cells, and T and B cells. As such, iNKTs serve as a powerful tool for use in cell-based cancer immunotherapy. iNKT cell activation commonly requ...
Autores principales: | Patel, Nishant P., Guan, Peng, Bahal, Devika, Hashem, Tanwir, Scheuplein, Felix, Schaub, Robert, Nichols, Kim E., Das, Rupali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352964/ https://www.ncbi.nlm.nih.gov/pubmed/32560408 http://dx.doi.org/10.3390/ijms21124317 |
Ejemplares similares
-
Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques
por: Bond, Nell G., et al.
Publicado: (2022) -
SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function
por: Bahal, Devika, et al.
Publicado: (2019) -
A Humanized Monoclonal Antibody Specific for Invariant Natural Killer T (iNKT) Cells for In Vivo Depletion
por: Scheuplein, Felix, et al.
Publicado: (2013) -
Ruxolitinib Ameliorates Airway Hyperresponsiveness and Lung Inflammation in a Corticosteroid-Resistant Murine Model of Severe Asthma
por: Subramanian, Hariharan, et al.
Publicado: (2021) -
Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control
por: Guan, Peng, et al.
Publicado: (2020)